PMC:7441788 / 17258-17674 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T179","span":{"begin":134,"end":135},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Mahévas et al [53]. Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. Relatively larger sample size in HCQ treatment and control groups. Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T222","span":{"begin":42,"end":47},"obj":"Chemical"},{"id":"T223","span":{"begin":65,"end":70},"obj":"Chemical"},{"id":"T224","span":{"begin":127,"end":132},"obj":"Chemical"},{"id":"T225","span":{"begin":232,"end":237},"obj":"Chemical"}],"attributes":[{"id":"A222","pred":"chebi_id","subj":"T222","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A223","pred":"chebi_id","subj":"T223","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A224","pred":"chebi_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A225","pred":"chebi_id","subj":"T225","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Mahévas et al [53]. Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. Relatively larger sample size in HCQ treatment and control groups. Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T127","span":{"begin":0,"end":19},"obj":"Sentence"},{"id":"T128","span":{"begin":20,"end":238},"obj":"Sentence"},{"id":"T129","span":{"begin":239,"end":305},"obj":"Sentence"},{"id":"T130","span":{"begin":306,"end":416},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Mahévas et al [53]. Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. Relatively larger sample size in HCQ treatment and control groups. Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"667","span":{"begin":38,"end":41},"obj":"Chemical"},{"id":"668","span":{"begin":79,"end":82},"obj":"Chemical"},{"id":"669","span":{"begin":228,"end":231},"obj":"Chemical"},{"id":"670","span":{"begin":272,"end":275},"obj":"Chemical"},{"id":"710","span":{"begin":170,"end":175},"obj":"Disease"}],"attributes":[{"id":"A669","pred":"pubann:denotes","subj":"669","obj":"MESH:D006886"},{"id":"A668","pred":"pubann:denotes","subj":"668","obj":"MESH:D006886"},{"id":"A667","pred":"pubann:denotes","subj":"667","obj":"MESH:D006886"},{"id":"A670","pred":"pubann:denotes","subj":"670","obj":"MESH:D006886"},{"id":"A710","pred":"pubann:denotes","subj":"710","obj":"MESH:D003643"}],"text":"Mahévas et al [53]. Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. Relatively larger sample size in HCQ treatment and control groups. Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced."}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T64","span":{"begin":170,"end":175},"obj":"http://purl.obolibrary.org/obo/GO_0016265"}],"text":"Mahévas et al [53]. Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. Relatively larger sample size in HCQ treatment and control groups. Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced."}

{"project":"LitCovid-PubTator","denotations":[{"id":"667","span":{"begin":38,"end":41},"obj":"Chemical"},{"id":"668","span":{"begin":79,"end":82},"obj":"Chemical"},{"id":"669","span":{"begin":228,"end":231},"obj":"Chemical"},{"id":"670","span":{"begin":272,"end":275},"obj":"Chemical"},{"id":"710","span":{"begin":170,"end":175},"obj":"Disease"}],"attributes":[{"id":"A667","pred":"tao:has_database_id","subj":"667","obj":"MESH:D006886"},{"id":"A668","pred":"tao:has_database_id","subj":"668","obj":"MESH:D006886"},{"id":"A669","pred":"tao:has_database_id","subj":"669","obj":"MESH:D006886"},{"id":"A670","pred":"tao:has_database_id","subj":"670","obj":"MESH:D006886"},{"id":"A710","pred":"tao:has_database_id","subj":"710","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Mahévas et al [53]. Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. Relatively larger sample size in HCQ treatment and control groups. Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced."}

{"project":"LitCovid-sentences","denotations":[{"id":"T127","span":{"begin":0,"end":19},"obj":"Sentence"},{"id":"T128","span":{"begin":20,"end":238},"obj":"Sentence"},{"id":"T129","span":{"begin":239,"end":305},"obj":"Sentence"},{"id":"T130","span":{"begin":306,"end":416},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Mahévas et al [53]. Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. Relatively larger sample size in HCQ treatment and control groups. Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced."}